NorthRock Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$588K Buy
2,099
+132
+7% +$34.7K 0.01% 406
2026
Q1
$525K Buy
1,967
+96
+5% +$26K 0.01% 407
2025
Q4
$469K Sell
1,871
-962
-34% -$255K 0.01% 381
2025
Q3
$813K Buy
2,833
+1,995
+238% +$535K 0.01% 390
2025
Q2
$220K Buy
+838
New +$204K 0.01% 619

Other funds holding LH

NorthRock Partners's LH Position: Q2 2026 in Review

NorthRock Partners increased its Labcorp (LH) stake by 6.7% in Q2 2026, buying an estimated $34.7K and bringing the position to 2,099 shares worth $588K. The position accounts for 0.01% of the portfolio, ranked #406.

NorthRock Partners first reported a position in LH in Q2 2025 and has held it in 5 quarters since. The position peaked at $813K in Q3 2025. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • NorthRock Partners held 2,099 shares of Labcorp worth $588K as of Q2 2026.
  • NorthRock Partners bought 132 Labcorp shares in Q2 2026, an estimated $34.7K.
  • Labcorp made up 0.01% of NorthRock Partners's portfolio in Q2 2026, its #406 holding.
  • NorthRock Partners first reported a position in Labcorp in Q2 2025 and has held it in 5 quarters since.
  • NorthRock Partners's Labcorp position peaked at $813K in Q3 2025.
  • 1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.